Merck KGaA's head of global R&D and CMO gives an overview of the company's programs and its appetite for business development
Danny Bar-Zohar describes Merck KGaA's three pillars of healthcare research: oncology, neurology, and immunology. Plus, the advantages of the company's heritageand location in Germany.
Comments